Restoration - Beximco Pharmaceuticals PLC

Summary by AI ^BETAClose X

Trading in Beximco Pharmaceuticals PLC's Global Depositary Receipts, each representing one ordinary share of BDT10, has been restored on AIM effective from 7:30 am on June 26, 2026. The temporary suspension was lifted following the publication of the company's annual audited accounts.

Disclaimer*

AIM

26 June 2026

NOTICE

26/06/2026 7:30am

RESTORATION OF TRADING ON AIM

BEXIMCO PHARMACEUTICALS PLC

Trading on AIM for the under-mentioned securities was temporarily suspended. The suspension is lifted from 26/06/2026 7:30am, the annual audited accounts having been published.

GLOBAL DEPOSITARY RECEIPTS (EACH REPRESENTING 1 ORDINARY SHARE OF BDT10 EACH), FULLY PAID

(B0DM5S5) (US0885792061)

If you have any queries relating to the above, please contact the company's nominated adviser on +44 (0)20 3368 3551 / 3555.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END